pentobarbital will minimize the level or effect of trazodone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lessen the extent or impact of bexarotene by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will reduce the level or outcome of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Physical exercise caution every time a barbiturate is administered to the nursing woman; tiny quantities of barbiturates are excreted during the milk
pentobarbital will minimize the extent or result of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Contraindicated (1)pentobarbital will lessen the level or result of roflumilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital will decrease the extent or outcome of suvorexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Sturdy CYP3A4 inducers may possibly lower suvorexant efficacy; if improved suvorexant dose necessary, usually do not exceed 20 mg/working day
pentobarbital will lessen the level or impact of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. read more Insignificant/Importance Unfamiliar.
pentobarbital decreases effects of hemin by pharmacodynamic antagonism. Use Caution/Watch. Drugs that improve delta-aminolevulinic acid synthetase may well decrease hemin result.
pentobarbital will reduce the level or result of cortisone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will decrease the extent or influence of felodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
Contraindicated. CYP3A4 is chargeable for the development and elimination of cariprazine's Energetic metabolites. The effect of CYP3A4 inducers on cariprazine publicity has not been evaluated and the Web impact is unclear.
With therapeutic doses of TCAs, barbiturates maximize metabolism and reduce blood concentrations of TCAs.